Alnylam Pharmaceuticals I... (ALNY)
234.56
4.06 (1.76%)
At close: Apr 17, 2025, 3:59 PM
234.77
0.09%
After-hours: Apr 17, 2025, 06:18 PM EDT
Alnylam Pharmaceuticals Revenue
Alnylam Pharmaceuticals reported an annual revenue of $2.25B, reflecting a 22.97% growth. For the quarter ending December 31, 2024, Alnylam Pharmaceuticals generated $593.17M in revenue.
Revenue (ttm)
$2.25B
Revenue Growth
22.97%
Price / Sales Ratio
13.46
Revenue / Employee
$1.01M
Employees
2,230
Market Cap
30.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.25B | +22.97% |
| Dec 31, 2023 | 1.83B | +76.23% |
| Dec 31, 2022 | 1.04B | +22.88% |
| Dec 31, 2021 | 844.29M | +71.31% |
| Dec 31, 2020 | 492.85M | n/a |